Home > Insider Trading > Filing (0001209191-21-041158)

Filing Details

Accession Number:: 0001209191-21-041158
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-06-16 20:13:37
Reporting Period:: 2021-06-14

Accepted Time:: 2021-06-16 20:13:37
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1564824	Allakos Inc.	ALLK	Pharmaceutical Preparations (2834)	454798831

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1637219	Adam Tomasi	975 Island Drive, Suite 201 Redwood City CA 94065	President And Coo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2021-06-15	20,000	$91.03	148,220	No	4	S	Direct
Common Stock	Acquisiton	2021-06-15	20,000	$0.69	168,220	No	4	M	Direct
Common Stock	Disposition	2021-06-14	20,000	$91.62	148,220	No	4	S	Direct
Common Stock	Acquisiton	2021-06-14	20,000	$0.69	168,220	No	4	M	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to buy)	Disposition	2021-06-15	20,000	$0.00	20,000	$0.69
Common Stock	Stock Option (Right to buy)	Disposition	2021-06-14	20,000	$0.00	20,000	$0.69

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
486,400		2027-05-17	No	4	M	Direct
506,400		2027-05-17	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	3,953	Indirect	See footnote

Footnotes

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2020. This transaction was executed in multiple trades at prices ranging from $90.01 to $92.21 per share. The sale price reported represents the weighted average sale price . Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person hereby undertakes to provide full information regarding the number of shares sold at each separate price.
Includes shares of common stock purchased under the Company's 2018 Employee Stock Purchase Plan.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2020. This transaction was executed in multiple trades at prices ranging from $90.00 to $94.65 per share. The sale price reported represents the weighted average sale price . Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person hereby undertakes to provide full information regarding the number of shares sold at each separate price.
Includes 3,953 shares received as a pro-rata in-kind distribution of Common Stock of the Issuer by Alta Partners Management VIII, LLC (APM VIII), without consideration, to the reporting person as a non-managing member of APM VIII.
The shares are held by Mr. Tomasi and Carrie Tomasi, as Trustees of the Tomasi Living Trust dated July 14, 2017.
On May 17, 2017, the Reporting Person was granted an option to purchase 706,400 ordinary shares pursuant to the Company's 2012 Equity Incentive Plan. The option vests as to one-fourth of the shares on May 17, 2018, and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.